0001876708-21-000001.txt : 20210806 0001876708-21-000001.hdr.sgml : 20210806 20210806140710 ACCESSION NUMBER: 0001876708-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210806 DATE AS OF CHANGE: 20210806 EFFECTIVENESS DATE: 20210806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoImmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001876708 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-409127 FILM NUMBER: 211152315 BUSINESS ADDRESS: STREET 1: 251 LITTLE FALLS DRIVE CITY: WILMINGTON STATE: DE ZIP: 19808 BUSINESS PHONE: 4692222350 MAIL ADDRESS: STREET 1: 251 LITTLE FALLS DRIVE CITY: WILMINGTON STATE: DE ZIP: 19808 D 1 primary_doc.xml X0708 D LIVE 0001876708 CytoImmune Therapeutics, Inc. 1218 S 5th Ave Monrovia CA CALIFORNIA 91016 4692222350 DELAWARE None None Corporation true 2020 Aleksey Krylov 1218 S 5th Ave Monrovia CA CALIFORNIA 91016 Executive Officer Will Rosellini 1218 S 5th Ave Monrovia CA CALIFORNIA 91016 Executive Officer Richard T Santulli 1218 S 5th Ave Monrovia CA CALIFORNIA 91016 Executive Officer Kinam Hong 1218 S 5th Ave Monrovia CA CALIFORNIA 91016 Director Douglas Williams 1218 S 5th Ave Monrovia CA CALIFORNIA 91016 Director Biotechnology Decline to Disclose 06b false 2021-07-23 false true true Preferred Stock can convert to underlying shares of Common Stock. false 0 Lifesci Capital 168404 Lifesci Capital 168404 250 West 55th St New York NY NEW YORK 10019 NY NEW YORK false 100343439 36543424 63800015 false 4 880000 0 0 false CytoImmune Therapeutics, Inc. Aleksey Krylov Aleksey Krylov Chief Financial Officer 2021-08-06